In this study, we further analysed the in vivo effects of NP-1 on weight loss, anorectic actions and liver steatosis in the (fa/fa) Zucker model, a context of leptin resistance that promotes hyperphagia11–13. This evidence concerns the gene LEP and fatty liver disease.